Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

FDA & EMA

FDA Grants Breakthrough Status to First Viral-Integration MRD Liquid Biopsy in Hepatocellular Carcinoma

ONCOLife

Daraxonrasib Doubles Overall Survival in Previously Treated Metastatic Pancreatic Cancer

FDA & EMA

FDA Grants Priority Review to Ifinatamab Deruxtecan in Pretreated ES-SC Lung Cancer

ONCOLife

MD Anderson Study Identifies DPY30 as Therapeutic Target in Pancreatic Cancer

ONCOLife

New Strategy Blocks NMD, Unmasks Hidden Tumor Antigens, and Boosts Immunotherapy

ONCOLife

Blocking DHODH Helps Triple Combination Overcome Resistance in Lung Cancer

ONCOLife

New B7-H3 Radio-Theranostic Promises to Broaden Targeted Radiation Across Solid Tumors

ONCOLife

Immunotherapy Boosts Chemo Cutting Recurrence Risk by 50% in Colon Cancer

ONCOLife

New IHC Biomarker Test Predicts Which Gastric Cancer Patients Benefit from Immunotherapy

ONCOLife Issues

Featured Articles

Ozekibart Plus FOLFIRI Shows Encouraging Late-Line Activity in Metastatic Colorectal Cancer

22 April 2026

Updated Phase 1/2 data show that ozekibart plus FOLFIRI produced a 20% objective response rate and an 87% disease control rate in heavily pretreated metastatic or unresectable colorectal cancer, where historical response rates are typically 1% to 6%....

Trending Articles

Targeted Bladder Cancer Therapy Erda-iDRS Achieves 89% Response Rate and PDC

Atirmociclib Reduces Progression Risk by 40% in CDK4/6 Metastatic Breast Cancer

ONCOLife

17 March 2026

TALAPRO-3 Trial Supports Early Use of Talazoparib in HRR+ mCS Prostate Cancer

ONCOLife

20 March 2026

FDA Approves Nivolumab-AVD as First Immunotherapy Combination for Hodgkin Lymphoma

FDA & EMA

20 March 2026

Abenacianine Enters Phase 3 to Enhance Real-Time Tumor Detection in Lung Surgery

ONCOLife

19 March 2026

CellCarta Secures Global Exclusivity for Aspyre Lung to Advance Lung Cancer Testing

Reengineering CAR-T Cells to Last Longer in the Fight Against Cancer and HIV

ONCOLife

15 March 2026

Vitamin B2’s Hidden Role in Cancer Survival May Open a New Therapeutic Target

ONCOLife

14 March 2026

Romiplostim Prevents Chemotherapy Side Effects and Preserves Treatment Intensity

ONCOLife

14 March 2026

PSMA PET/CT May Transform Prostate Cancer Diagnosis and Reduce Biopsies by 50%

ONCOLife

13 March 2026

Breast Cancer Patients Choosing Alternative Medicine Face Four Times Higher Mortality

Designing Digital Healthcare Systems for the Future of Patient-Centered Care

Digital Health

4 March 2026

Gut Bacteria Decide Whether Nutrients Feed Tumors or Fuel Immunity

ONCOLife

13 February 2026

Amivantamab Plus Chemotherapy Shows Promising Responses in Colorectal Cancer

Clinical Trials

11 January 2026

Novartis Expands US Radioligand Manufacturing With $23 Billion Investment in Florida

Pharma

9 January 2026